Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Prestige Consumer Healthcare Inc. before investing.

In this article, we go over a few key elements for understanding Prestige Consumer Healthcare Inc.’s stock price such as:

• Prestige Consumer Healthcare Inc.’s current stock price and volume
• Why Prestige Consumer Healthcare Inc.’s stock price changed recently
• Upgrades and downgrades for PBH from analysts
• PBH’s stock price momentum as measured by its relative strength

About Prestige Consumer Healthcare Inc. (PBH)

Before we jump into Prestige Consumer Healthcare Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under Debrox brand name. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Want to learn more about Prestige Consumer Healthcare Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Prestige Consumer Healthcare Inc..

Prestige Consumer Healthcare Inc.’s Stock Price as of Market Close

As of April 17, 2026, 4:00 PM, CST, Prestige Consumer Healthcare Inc.’s stock price was $58.130.

Prestige Consumer Healthcare Inc. is up 1.89% from its previous closing price of $57.050.

During the last market session, Prestige Consumer Healthcare Inc.’s stock traded between $57.350 and $58.810. Currently, there are approximately 47.88 million shares outstanding for Prestige Consumer Healthcare Inc..

Prestige Consumer Healthcare Inc.’s price-earnings (P/E) ratio is currently at 15.3, which is low compared to the Pharmaceuticals industry median of 19.8. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Prestige Consumer Healthcare Inc. Stock Price History

Prestige Consumer Healthcare Inc.’s (PBH) price is currently down 1.92% so far this month.

During the month of April, Prestige Consumer Healthcare Inc.’s stock price has reached a high of $60.350 and a low of $51.240.

Over the last year, Prestige Consumer Healthcare Inc. has hit prices as high as $89.370 and as low as $51.240. Year to date, Prestige Consumer Healthcare Inc.’s stock is down 5.77%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Prestige Consumer Healthcare Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 17, 2026, there were 0 analysts who downgraded Prestige Consumer Healthcare Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Prestige Consumer Healthcare Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Prestige Consumer Healthcare Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Prestige Consumer Healthcare Inc.’s current valuation based on AAII’s Value Grade is a B, which means it is considered to be Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Prestige Consumer Healthcare Inc. (PBH) by visiting AAII Stock Evaluator.

Relative Price Strength of Prestige Consumer Healthcare Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 17, 2026, Prestige Consumer Healthcare Inc. has a weighted four-quarter relative price strength of -13.70%, which translates to a Momentum Score of 16 and is considered to be Very Weak.

Want to learn more about how Prestige Consumer Healthcare Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Prestige Consumer Healthcare Inc. Stock Price: Bottom Line

As of April 17, 2026, Prestige Consumer Healthcare Inc.’s stock price is $58.130, which is up 1.89% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Prestige Consumer Healthcare Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.